|
|
Expert consensus on nutritional therapy for patients with nasopharyngeal carcer |
Chinese Anti-Cancer Association, Chinese Society for Oncological Nutrition and Supportive Care, The Committee of Rehabilitation and Palliative Care, Chinese Clinical Nutritionist Center, Chinese Nutrition Society of Clinical Nutrition, Electronic Journal of Metabolism and Nutrition of Cancer |
|
|
Abstract Nasopharyngeal carcinoma (NPC) is a malignant tumor that occurs in nasopharyngeal mucosa epithelium. About 80% of NPCs occur in China, which seriously endanger people's health and life safety and NPCs are one of the malignant tumors that China focuses on prevention and treatment. Malnutrition has become a common clinical complication in NPC patients due to the disease itself and anti-tumor therapy. Among them, NPC patients receiving radiotherapy are one of the groups with the highest incidence of malnutrition. Malnutrition seriously affects the prognosis of NPC patients. Reasonable nutritional therapy has a positive impact on the quality of life and prognosis of patients with NPC. According to the patient's condition, choosing the best time and taking appropriate nutritional therapy play a key role to ensure the success of patients with radiotherapy and chemotherapy, and thus affect the patient's recovery and prognosis. It should be emphasized that no matter what nutritional treatment (enteral or parenteral nutrition) the patients should be evaluated first. The patient's nutritional status and energy needs should be formulated and adjusted according to the changes in weight and related indicators in order to improve patients' tolerance to radiotherapy and chemotherapy, to reduce adverse reactions, and to improve quality of life.
|
|
|
|
|
Cite this article: |
Chinese Anti-Cancer Association,Chinese Society for Oncological Nutrition and Supportive Care,The Committee of Rehabilitation and Palliative Care, et al. Expert consensus on nutritional therapy for patients with nasopharyngeal carcer[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(1): 30-32.
|
|
|
|
URL: |
http://www.ejmnc.org/EN/ OR http://www.ejmnc.org/EN/Y2018/V5/I1/30 |
[1] |
1FAN Yue-ping, 2ZHANG Tian, 2QU Qian-nuo, 3SHI Han-ping. Interpretation of expert consensus for nutritional therapy pathway of malignant tumor in China—peripheral venous catheterization[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 301-304. |
[2] |
CHENG Guo-wei, SUN Li, CHEN Ping, HE Xiang-ling, SU Dan, XI Heng-zhi, ZANG Ding-qi. Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 332-336. |
[3] |
1,2GENG Bi-zhu, 1ZHENG Jin. Review of family nutrition support research during the intermission of chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 386-390. |
[4] |
GAO Chun, LI Meng, WEI Jun-min, LI Yu-zhen, TIAN Wei-jun, JIANG Hai-ping, SHEN Wei, XU Ai-guo, YU Zhen, CHEN Dong-sheng, CHEN Lian-zhen, GUAN Wen-xian, JIANG Hua, LI Da-kui, MEI Dan, YU Ji-ren, ZHAO C. Expert consensus on clinical use of compound amino acid injection[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 183-189. |
[5] |
LI Na, LIU Jie, LIN Xin, ZHANG Hong-mei, ZHANG Meng-yuan, SHI Mu-li, HE Xiu-mei, XU Hong-xia. null[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 200-205. |
[6] |
CHANG Ge-yun. Immune enteral nutrition on advanced gastrointestinal cancer patients undergoing apatinib[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 230-235. |
|
|
|
|